C Hohberg

1.1k total citations
31 papers, 929 citations indexed

About

C Hohberg is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, C Hohberg has authored 31 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in C Hohberg's work include Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diabetes Management and Research (10 papers). C Hohberg is often cited by papers focused on Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diabetes Management and Research (10 papers). C Hohberg collaborates with scholars based in Germany, Japan and Denmark. C Hohberg's co-authors include Thomas Först, Andreas Pfützner, G Lübben, Thomas R. Konrad, Peter Herbert Kann, Matthias Langenfeld, S Först, T. Kunt, A Pfützner and Volkmar H.R. Schmid and has published in prestigious journals such as Circulation, Diabetes Care and Atherosclerosis.

In The Last Decade

C Hohberg

29 papers receiving 882 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
C Hohberg 566 265 260 191 144 31 929
Hasan Altunbaş 525 0.9× 201 0.8× 349 1.3× 128 0.7× 109 0.8× 49 1.1k
Yoshihito Atsumi 608 1.1× 324 1.2× 220 0.8× 131 0.7× 225 1.6× 63 1.2k
Outi Heikkilä 568 1.0× 132 0.5× 251 1.0× 148 0.8× 248 1.7× 20 1.1k
M. Rema 765 1.4× 168 0.6× 121 0.5× 241 1.3× 225 1.6× 30 1.9k
Kustaa Hietala 617 1.1× 134 0.5× 183 0.7× 152 0.8× 210 1.5× 26 1.2k
Ching-Chu Chen 415 0.7× 328 1.2× 143 0.6× 255 1.3× 144 1.0× 29 1.1k
Wenjia Yang 642 1.1× 310 1.2× 240 0.9× 99 0.5× 83 0.6× 59 1.1k
Fone‐Ching Hsiao 256 0.5× 241 0.9× 161 0.6× 165 0.9× 133 0.9× 42 848
Jun‐Sing Wang 411 0.7× 226 0.9× 152 0.6× 134 0.7× 159 1.1× 93 1.0k
Aaron Wong 347 0.6× 427 1.6× 241 0.9× 136 0.7× 316 2.2× 30 1.1k

Countries citing papers authored by C Hohberg

Since Specialization
Citations

This map shows the geographic impact of C Hohberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Hohberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Hohberg more than expected).

Fields of papers citing papers by C Hohberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Hohberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Hohberg. The network helps show where C Hohberg may publish in the future.

Co-authorship network of co-authors of C Hohberg

This figure shows the co-authorship network connecting the top 25 collaborators of C Hohberg. A scholar is included among the top collaborators of C Hohberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Hohberg. C Hohberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schloot, Nanette C., et al.. (2016). Zwei Insulin-glargin-Formulierungen im Vergleich. MMW - Fortschritte der Medizin. 158(S5). 19–27. 1 indexed citations
2.
Schloot, Nanette C., et al.. (2015). Anforderungen an Biosimilars und biosimilares Insulin. Diabetologie und Stoffwechsel. 10(6). 334–342. 1 indexed citations
3.
Först, Thomas, et al.. (2010). Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β ‐cell protection in individuals with type 2 diabetes. Diabetes Obesity and Metabolism. 12(5). 437–441. 15 indexed citations
4.
Pfützner, Andreas, Michael Derwahl, Stephan Jacob, et al.. (2010). Limitations of the HOMA-B Score for Assessment of β -Cell Functionality in Interventional Trials—Results from the PIOglim study. Diabetes Technology & Therapeutics. 12(8). 599–604. 16 indexed citations
5.
Hohberg, C, Andreas Pfützner, Thomas Först, et al.. (2009). Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β‐cell function: results from the PioSwitch Study. Diabetes Obesity and Metabolism. 11(5). 464–471. 16 indexed citations
6.
Först, Thomas, C Hohberg, & Andreas Pfützner. (2009). Cardiovascular Effects of Disturbed Insulin Activity in Metabolic Syndrome and in Type 2 Diabetic Patients. Hormone and Metabolic Research. 41(2). 123–131. 25 indexed citations
7.
8.
9.
Först, Thomas, et al.. (2008). Reliability of Lightguide Spectrophotometry (O2C®) for the Investigation of Skin Tissue Microvascular Blood Flow and Tissue Oxygen Supply in Diabetic and Nondiabetic Subjects. Journal of Diabetes Science and Technology. 2(6). 1151–1156. 70 indexed citations
10.
Pfützner, A, et al.. (2008). Prefilled insulin device with reduced injection force: patient perception and accuracy. Current Medical Research and Opinion. 24(9). 2545–2549. 42 indexed citations
11.
Pfützner, Andreas, M Hanefeld, G Lübben, et al.. (2007). Visfatin: A Putative Biomarker for Metabolic Syndrome is not Influenced by Pioglitazone or Simvastatin Treatment in Nondiabetic Patients at Cardiovascular Risk - Results from the PIOSTAT Study. Hormone and Metabolic Research. 39(10). 764–768. 28 indexed citations
12.
Först, Thomas, Efstratios Karagiannis, G Lübben, et al.. (2007). Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease. Atherosclerosis. 197(1). 311–317. 36 indexed citations
13.
14.
Schöndorf, Thomas, G Lübben, Markus Hoopmann, et al.. (2007). Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus. Gynecological Endocrinology. 23(6). 356–360. 10 indexed citations
15.
Schöndorf, Thomas, Thomas Först, C Hohberg, et al.. (2007). Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitus.. PubMed. 53(3-4). 193–8. 1 indexed citations
16.
Pfützner, Andreas, Eberhard Standl, Jan Schulze, et al.. (2006). Association of high-sensitive C-reactive protein with advanced stage β-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clinical Chemistry and Laboratory Medicine (CCLM). 44(5). 556–60. 23 indexed citations
17.
18.
Pfützner, Andreas, Eberhard Standl, C Hohberg, et al.. (2005). IRIS II Study: Intact Proinsulin Is Confirmed as a Highly Specific Indicator for Insulin Resistance in a Large Cross-Sectional Study Design. Diabetes Technology & Therapeutics. 7(3). 478–486. 24 indexed citations
19.
Först, Thomas, Eberhard Standl, C Hohberg, et al.. (2004). IRIS II study: the IRIS II score—assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetes. Diabetic Medicine. 21(10). 1149–1153. 13 indexed citations
20.
Pfützner, Andreas, T. Kunt, C Hohberg, et al.. (2004). Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes. Diabetes Care. 27(3). 682–687. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hasan Altunbaş Breakdown of academic impact, for papers by Yoshihito Atsumi Breakdown of academic impact, for papers by Outi Heikkilä Breakdown of academic impact, for papers by M. Rema Breakdown of academic impact, for papers by Kustaa Hietala Breakdown of academic impact, for papers by Ching-Chu Chen Breakdown of academic impact, for papers by Wenjia Yang Breakdown of academic impact, for papers by Fone‐Ching Hsiao Breakdown of academic impact, for papers by Jun‐Sing Wang Breakdown of academic impact, for papers by Aaron Wong
Rankless by CCL
2026